Interview With Anthony Tennyson

We speak with Anthony Tennyson, CEO of Awakn Life Sciences, a biotechnology company with clinical operations developing and delivering psychedelic medicine to treat addiction.
HGTV Star Christina Haack Says Smoking Bufo Toad Cured Her Anxiety in '15 Minutes'

HGTV Star Christina Haack Says Smoking Bufo Toad Cured Her Anxiety in ‘15 Minutes’

The famous interior designer known for renovating and flipping houses credits the potent psychoactive substance for resetting her brain.
Psychedelic Business Spotlight

Psychedelic Business Spotlight: July 9, 2021

,
This week in psychedelic business news: It’s all about partnerships and acquisitions designed to advance psychedelic therapies for depression, suicidal ideation, pain, and more.

Numinus & Cybin Forge MASSIVE DEALS ( NUMI / CYBN )

BIG news for Cybin Inc. (CYBN: NEO) (CLXPF: OTC) and Numinus Wellness (NUMI: NEO) (LKYSF: OTC). First and foremost, Numinus announced that the company acquired NCT, a Toronto-based, fully operational neurology center with 13 doctors, 8 allied health staff, nurse practitioners, and physician assistants. NCT and Numinus plan to establish the first center for excellence in psychedelic neurology. Speaking of centers of excellence, Cybin entered into an agreement with a company called Greenbrook TMS to establish mental health centers of excellence in order to facilitate R & D of psychedelic compound-based therapeutics for patients suffering from depression. Why is this big news? Watch till the end to find out! In other news, we are glad to announce that The Psychedelic Investor has entered into a collaboration with Psychedelic Spotlight, one of the biggest news sources for psychedelic-related news. Twice a month, I will be discussing some of the major industry news among other psychedelic industry experts in Psychedelic Spotlight's segment titled: "Spotlight Roundup". Check out my first appearance on their podcast by clicking the link below! https://www.youtube.com/watch?v=UKGFXnsOlr8 Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news! Timestamps 0:00 -Intro 2:40 - Numinus Acquisition of Neurology Center of Toronto 9:55 -Cybin Enters Agreement with Greenbrook Links: NUMINUS WELLNESS TO ACQUIRE NEUROLOGY CENTRE OF TORONTO, PLANS TO CREATE CENTRE FOR PSYCHEDELIC NEUROLOGY: https://thepsychedelicinvestor.com/2021/07/06/numinus-wellness-to-acquire-neurology-centre-of-toronto-plans-to-create-centre-for-psychedelic-neurology/ CYBIN (NEO: CYBN, OTC: CLXPF) ENTERS INTO COLLABORATION AGREEMENT WITH GREENBROOK TMS TO ESTABLISH MENTAL HEALTH CENTERS OF EXCELLENCE: https://thepsychedelicinvestor.com/2021/07/08/cybin-enters-into-collaboration-agreement-with-greenbrook-tms-to-establish-mental-health-centers-of-excellence/ Enjoy the episode! Follow us on social media! 🙌 Instagram: @thepsychedelicinvestor Facebook: @thepsychedelicinvestor Want to collaborate? Send us an email at: thepsychedelicinvestor@gmail.com Music from: www.bensound.com Video editing: @themyaholy Check out our Benziga discounts https://benzinga.grsm.io/jameshallifax1834 https://benzinga.grsm.io/thepsychedelicinvestor DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments. All of the information in this video is public information that James (The Psychedelic Investor) believes to be reliable but it is not guaranteed to be 100% accurate and as such should not be used as advice. Any opinions or thoughts from James (The Psychedelic Investor) are subject to change. #Numinus #Cybin #NUMIStock
Michael Pollan advice for talking to kids about drugs

Michael Pollan’s Advice on Talking to Kids About Psychedelic Drugs: ‘They Need to Be Treated with Respect’

"We can begin to talk to children about drugs in a very different way than they're learning in school," the popular author says.

The Spotlight Roundup-The First-Ever Female Founded Psychedelic Company

July 7, 2021- This week’s Psychedelic Business News top stories include: - Mydecine Innovations Group Makes A Huge Mushroom Discovery - Field Trip Health Prepares for the Nasdaq - Psychedelic Research Makes It's Way To Texas - We Introduce…
Third California City Considers Decriminalizing Psychedelics

Another California City Proposes Decriminalizing Psychedelics

Decriminalization is one step behind legalization. Selling entheogenic plants or fungi remains a felony that could warrant prison time.
Psilocybin depression treatment

Psychedelic Biotech Company Cybin Partners with Greenbrook to Develop Innovative Depression Treatment

, ,
Cybin CEO says agreement "serves as a major step toward establishing a national distribution network for future psychedelic therapies."

Single Dose of Psilocybin Strengthens Brain Connections in Mice, According to Yale Study

“It was a real surprise to see such enduring changes from just one dose of psilocybin," says senior study author Alex Kwan.
Numinus Wellness To Acquire Neurology Centre of Toronto, Plans to Create Centre for Psychedelic Neurology

Numinus Wellness to Acquire Neurology Centre of Toronto to Create Psychedelic Treatment Facility

,
NCT will utilize Numinus' expertise in psychedelic-assisted therapy to create a specialization in the application of psychedelics in the field of neurology